Associate Professor in residence, Family Medicine, University of California Los Angeles David Geffen SOM
Internal Medicine
Dr. Keith G. Heinzerling, MD
|
|
Give Review
Keith Heinzerling works in the field of Internal Medicine. He studied medicine at Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Keith Heinzerling is a published MD. He has 24 publications published. The most current publication "Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study." He is registered with Medicare.
Publications
- Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methampheta...
- The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: A Double-Blind, Placebo-Controlled Laboratory Study.
- Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine use.
- Up in Smoke? A Preliminary Open-Label Trial of Nicotine Replacement Therapy and Cognitive Behavioral Motivational Enhancement for Smoking Cessation Among Youth in Los ...
- Pharmacotherapy of amphetamine-type stimulant dependence: An update.
- Pilot Randomized Trial of Bupropion for Adolescent Methamphetamine Abuse/Dependence.
- A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: Suggested guidelines for treatment discontinuation/augmentation.
- COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and Methamphetamine Dependence Treatment Response: Preliminary Investigation.
- Clinical correlates of health-related quality of life among opioid-dependent patients.
- The cardiovascular and subjective effects of methamphetamine combined with gamma-vinyl-gamma-aminobutyric acid (GVG) in non-treatment seeking methamphetamine-dependent...
- Approval of syringe exchange programs in California: results from a local approach to HIV prevention.
- Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence.
- Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes.
- Hospital utilization for injection drug use-related soft tissue infections in urban versus rural counties in California.
- Opportunities for the development of neuroimmune therapies in addiction.
- Randomized, placebo-controlled trial of baclofen and gabapentin for the treatment of methamphetamine dependence.
- Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.
- Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables.
- Treatment for amphetamine withdrawal.
- Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
- Double-blind placebo-controlled evaluation of the PROMETA™ protocol for methamphetamine dependence.
- Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.
- Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study.
Schools
Stanford Univ Sch Of Med
Nyu Hospitals Center
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
NYU School of Medicine -
Stanford University School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center -
Santa Monica-UCLA Medical Center and Orthopaedic Hospital
Drug Facts
| NPI NUMBER | 1184724932 | |
| NPPES Provider LastName | HEINZERLING | |
| NPPES Provider FirstName | KEITH | |
| NPPES Provider ZIPCode | 904043414 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 154.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 12.34 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1184724932 |
| Last Name Of The Provider | HEINZERLING |
| First Name Of The Provider | KEITH |
| View All |
Similar Doctors
|
|
Dr. Richard F. Levy, MD |
|
|
Dr. Jeffrey S. Goldsmith, MD |
|
Dr. Philip M. Bretsky, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter C. Galier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George C. Yen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cathy C. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ernie L. Prudente, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nathan Cox, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin S. Breger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Fisher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Digish D. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey D. Mayne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roger M. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amin Khorsandi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George A. Goldberg, MD |
|
|
Dr. Stephen J. Kania, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jim Blechman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven Wong, MD
This Doctor is OpenDoctor Recommended.
|